Safety and Clinical Activity of MEDI1873, a Novel GITR

Ani Balmanoukian

Ani Balmanoukian

Safety and Clinical Activity of MEDI1873, a Novel GITR
Agonist, in Advanced Solid Tumors

Ani S. Balmanoukian, Jeffrey R. Infante, Raid Aljumaily, Aung Naing, Ashish V. Chintakuntlawar, Naiyer A. Rizvi, Helen J. Ross, Michael Gordon, Philip R. Mallinder, Nairouz Elgeioushi, Ignacio Gonzalez-García, Nathan Standifer, Jennifer Cann, Nicholas Durham, Shahram Rahimian, Rakesh Kumar, and Crystal S. Denlinger

Clin Cancer Res 2020;26:6196–203
doi: 10.1158/1078-0432.CCR-20-0452
©2020 American Association for Cancer Research

More publications from Ani Balmanoukian

2021-11-06T07:21:44+01:00November 6, 2021|Other article for therapists|

Share This Story, Choose Your Platform!

Go to Top